ZA200805227B - N-(5-memebered heteroarmatic ring)-amido anti-viral compounds - Google Patents
N-(5-memebered heteroarmatic ring)-amido anti-viral compoundsInfo
- Publication number
- ZA200805227B ZA200805227B ZA200805227A ZA200805227A ZA200805227B ZA 200805227 B ZA200805227 B ZA 200805227B ZA 200805227 A ZA200805227 A ZA 200805227A ZA 200805227 A ZA200805227 A ZA 200805227A ZA 200805227 B ZA200805227 B ZA 200805227B
- Authority
- ZA
- South Africa
- Prior art keywords
- heteroarmatic
- memebered
- ring
- viral compounds
- amido
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74985505P | 2005-12-12 | 2005-12-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200805227B true ZA200805227B (en) | 2009-11-25 |
Family
ID=38163507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200805227A ZA200805227B (en) | 2005-12-12 | 2006-12-12 | N-(5-memebered heteroarmatic ring)-amido anti-viral compounds |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7595398B2 (xx) |
| EP (1) | EP1971597A2 (xx) |
| JP (1) | JP2009519346A (xx) |
| KR (1) | KR20080080170A (xx) |
| CN (1) | CN101331125A (xx) |
| AU (1) | AU2006326443A1 (xx) |
| BR (1) | BRPI0619730A2 (xx) |
| CA (1) | CA2633569A1 (xx) |
| IL (1) | IL191699A0 (xx) |
| RU (1) | RU2008128453A (xx) |
| TW (1) | TW200730476A (xx) |
| WO (1) | WO2007070600A2 (xx) |
| ZA (1) | ZA200805227B (xx) |
Families Citing this family (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200519106A (en) | 2003-05-02 | 2005-06-16 | Novartis Ag | Organic compounds |
| US7629340B2 (en) * | 2005-12-12 | 2009-12-08 | Smithkline Beecham Corporation | N-(6-membered aromatic ring)-amido anti-viral compounds |
| ES2389062T3 (es) | 2006-01-18 | 2012-10-22 | Amgen, Inc | Compuestos de tiazol como inhibidores de proteína cinasa B (PKB) |
| GB0608899D0 (en) * | 2006-05-05 | 2006-06-14 | Leuven K U Res & Dev | Novel viral replication inhibitors |
| US20100055071A1 (en) * | 2006-11-21 | 2010-03-04 | Martin Robert Leivers | Anti-Viral Compounds |
| TW200827368A (en) * | 2006-11-21 | 2008-07-01 | Genelabs Tech Inc | Amido anti-viral compounds |
| WO2008154601A1 (en) * | 2007-06-12 | 2008-12-18 | Genelabs Technologies, Inc. | Anti-viral inhibitors and methods of use |
| AU2008276512A1 (en) | 2007-07-17 | 2009-01-22 | Amgen Inc. | Thiadiazole modulators of PKB |
| CA2692713A1 (en) | 2007-07-17 | 2009-01-22 | Amgen Inc. | Heterocyclic modulators of pkb |
| EP2240475B1 (en) | 2007-12-20 | 2013-09-25 | Novartis AG | Thiazole derivatives used as pi 3 kinase inhibitors |
| US7704992B2 (en) * | 2008-02-13 | 2010-04-27 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| WO2009143361A1 (en) * | 2008-05-22 | 2009-11-26 | Smithkline Beecham Corporation | Amido anti-viral compounds |
| WO2009143359A2 (en) * | 2008-05-22 | 2009-11-26 | Smithkline Beecham Corporation | Amido anti-viral compounds |
| EP2293671A4 (en) | 2008-06-03 | 2012-03-21 | Siga Technologies Inc | SMALL MOLECULAR INHIBITORS FOR TREATING OR PREVENTING DENGUE INFECTIONS |
| UA104147C2 (uk) | 2008-09-10 | 2014-01-10 | Новартис Аг | Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань |
| WO2010096115A1 (en) | 2008-10-29 | 2010-08-26 | Apath, Llc | Compounds, compositions and methods for control of hepatitis c viral infections |
| WO2010066353A1 (de) * | 2008-12-11 | 2010-06-17 | Bayer Cropscience Ag | Thiazolyoximether und -hydrazone asl pflanzenschutzmittel |
| CN102245604A (zh) | 2008-12-23 | 2011-11-16 | 雅培制药有限公司 | 抗病毒化合物 |
| EP2367824B1 (en) * | 2008-12-23 | 2016-03-23 | AbbVie Inc. | Anti-viral derivatives of pyrimidine |
| SG174146A1 (en) | 2009-02-27 | 2011-10-28 | Enanta Pharm Inc | Hepatitis c virus inhibitors |
| CA2758484A1 (en) | 2009-04-15 | 2010-10-21 | David A. Degoey | Anti-viral compounds |
| MX2011013016A (es) | 2009-06-05 | 2012-04-20 | Link Medicine Corp | Derivados de aminopirrolidinona y usos de los mismos. |
| US9394279B2 (en) | 2009-06-11 | 2016-07-19 | Abbvie Inc. | Anti-viral compounds |
| US8937150B2 (en) | 2009-06-11 | 2015-01-20 | Abbvie Inc. | Anti-viral compounds |
| US8716454B2 (en) | 2009-06-11 | 2014-05-06 | Abbvie Inc. | Solid compositions |
| TWI402070B (zh) | 2009-06-11 | 2013-07-21 | Abbott Lab | 抗病毒化合物 |
| EA201200087A1 (ru) | 2009-07-02 | 2012-07-30 | Новартис Аг | 2-карбоксамиды циклоаминомочевин, которые являются ингибиторами pi3k |
| US8293753B2 (en) | 2009-07-02 | 2012-10-23 | Novartis Ag | Substituted 2-carboxamide cycloamino ureas |
| US8653070B2 (en) | 2009-12-14 | 2014-02-18 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
| KR20120118008A (ko) * | 2009-12-18 | 2012-10-25 | 아이데닉스 파마슈티칼스, 인코포레이티드 | 5,5-융합 아릴렌 또는 헤테로아릴렌 간염 ｃ 바이러스 억제제 |
| EP2550278A1 (en) * | 2010-03-24 | 2013-01-30 | Vertex Pharmaceuticals Incorporated | Analogues for the treatment or prevention of flavivirus infections |
| NZ605440A (en) | 2010-06-10 | 2014-05-30 | Abbvie Bahamas Ltd | Solid compositions comprising an hcv inhibitor |
| RU2436786C1 (ru) * | 2010-07-23 | 2011-12-20 | Александр Васильевич Иващенко | Замещенные индолы, противовирусный активный компонент, способ получения и применения |
| PH12013501436A1 (en) | 2011-01-04 | 2013-09-09 | Novartis Ag | Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd) |
| JPWO2012121168A1 (ja) * | 2011-03-04 | 2014-07-17 | 国立大学法人京都大学 | キナーゼ阻害剤 |
| US20120252721A1 (en) * | 2011-03-31 | 2012-10-04 | Idenix Pharmaceuticals, Inc. | Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor |
| US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
| WO2013030750A1 (en) | 2011-09-01 | 2013-03-07 | Lupin Limited | Antiviral compounds |
| US9309236B2 (en) | 2011-10-05 | 2016-04-12 | The Board Of Trustees Of The Leland Stanford Junior University | PI-kinase inhibitors with broad spectrum anti-infective activity |
| US9926309B2 (en) | 2011-10-05 | 2018-03-27 | The Board Of Trustees Of The Leland Stanford Junior University | Pi-kinase inhibitors with anti-infective activity |
| TWI640519B (zh) * | 2011-11-29 | 2018-11-11 | 泰緯生命科技股份有限公司 | Ｈｅｃ１活性調控因子及其調節方法 |
| US9034832B2 (en) | 2011-12-29 | 2015-05-19 | Abbvie Inc. | Solid compositions |
| CA2862755A1 (en) | 2012-02-10 | 2013-08-15 | Lupin Limited | Antiviral compounds with a dibenzooxaheterocycle moiety |
| ES2647124T3 (es) | 2012-06-28 | 2017-12-19 | Novartis Ag | Derivados de pirrolidina y su uso como moduladores de la ruta del complemento |
| JP6154897B2 (ja) | 2012-06-28 | 2017-06-28 | ノバルティス アーゲー | ピロリジン誘導体、および補体経路調節因子としてのその使用 |
| US9487483B2 (en) | 2012-06-28 | 2016-11-08 | Novartis Ag | Complement pathway modulators and uses thereof |
| ES2710491T3 (es) | 2012-06-28 | 2019-04-25 | Novartis Ag | Moduladores de la vía del complemento y sus usos |
| US9388199B2 (en) | 2012-06-28 | 2016-07-12 | Novartis Ag | Pyrrolidine derivatives and their use as complement pathway modulators |
| JP6238980B2 (ja) | 2012-07-12 | 2017-11-29 | ノバルティス アーゲー | 補体経路モジュレーターおよびその使用 |
| WO2014063167A1 (en) * | 2012-10-19 | 2014-04-24 | The Broad Institute, Inc. | Thiazole-based inhibitors of scavenger receptor bi |
| US11484534B2 (en) | 2013-03-14 | 2022-11-01 | Abbvie Inc. | Methods for treating HCV |
| WO2014145642A2 (en) * | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Nrf2 small molecule inhibitors for cancer therapy |
| EP3089757A1 (en) | 2014-01-03 | 2016-11-09 | AbbVie Inc. | Solid antiviral dosage forms |
| CN104844589B (zh) * | 2014-12-26 | 2018-04-20 | 中国科学院合肥物质科学研究院 | 一种pi3k激酶抑制剂 |
| EP3325452B1 (en) | 2015-07-24 | 2022-03-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Substituted hydrophobic benzene sulfonamide thiazole compounds for use in treating cancer |
| EP3419980B1 (en) | 2016-02-26 | 2025-01-01 | The Board of Trustees of the Leland Stanford Junior University | Pi-kinase inhibitors with anti-infective activity |
| AU2017275657B2 (en) | 2016-06-02 | 2021-08-19 | Novartis Ag | Potassium channel modulators |
| RS62899B1 (sr) | 2017-01-23 | 2022-03-31 | Cadent Therapeutics Inc | Modulatori kalijumovih kanala |
| WO2019046668A1 (en) * | 2017-08-31 | 2019-03-07 | Kezar Life Sciences | AMIDE-SUBSTITUTED THIAZOLES AS INHIBITORS OF SECRETIC PROTEIN |
| MX2021004647A (es) | 2018-10-22 | 2021-08-16 | Novartis Ag | Formas cristalinas de moduladores de los canales de potasio. |
| US20220099637A1 (en) | 2018-12-04 | 2022-03-31 | Bristol-Myers Squibb Company | Methods of analysis using in-sample calibration curve by multiple isotopologue reaction monitoring |
| EP3941909A4 (en) | 2019-03-21 | 2023-01-25 | The Board Of Trustees Of The Leland Stanford Junior University | Pi4-kinase inhibitors and methods of using the same |
| CN113683608B (zh) * | 2021-09-17 | 2023-05-09 | 深圳大学 | 具有杀菌活性的n-取代-2-氨基-4-糖精取代甲基噻唑类化合物、制备方法和应用 |
| WO2025150943A1 (ko) * | 2024-01-09 | 2025-07-17 | 주식회사 프로티나 | 신규 화합물 및 이의 용도 |
| CN118221610B (zh) * | 2024-05-27 | 2025-06-20 | 南京市鸿舜医药科技有限公司 | 一种苯基噻唑胺类PI4KIIIβ/HDAC双靶抑制剂、制备方法及其药物组合物和应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE68593B1 (en) * | 1989-12-06 | 1996-06-26 | Sanofi Sa | Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them |
| US5738985A (en) | 1993-04-02 | 1998-04-14 | Ribogene, Inc. | Method for selective inactivation of viral replication |
| US6399629B1 (en) * | 1998-06-01 | 2002-06-04 | Microcide Pharmaceuticals, Inc. | Efflux pump inhibitors |
| GB9823871D0 (en) | 1998-10-30 | 1998-12-23 | Pharmacia & Upjohn Spa | 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents |
| US6852752B2 (en) * | 1999-12-17 | 2005-02-08 | Vicuron Pharmaceuticals Inc. | Urea compounds, compositions and methods of use and preparation |
| US6797820B2 (en) * | 1999-12-17 | 2004-09-28 | Vicuron Pharmaceuticals Inc. | Succinate compounds, compositions and methods of use and preparation |
| DK1347971T3 (da) | 2000-12-21 | 2006-05-15 | Bristol Myers Squibb Co | Thiazolylinhibitorer af tyrosinkinaser fra Tec-familien |
| CZ20033368A3 (en) * | 2001-06-11 | 2004-04-14 | Shire Biochem Inc. | Thiophene derivatives as antiviral agents for flavivirus infection |
| DE10133665A1 (de) | 2001-07-11 | 2003-01-30 | Boehringer Ingelheim Pharma | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung |
| WO2004014852A2 (en) * | 2002-08-12 | 2004-02-19 | Bristol-Myers Squibb Company | Iminothiazolidinones as inhibitors of hcv replication |
| FR2876692B1 (fr) * | 2004-10-19 | 2007-02-23 | Sanofi Aventis Sa | Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique |
| GB0426661D0 (en) | 2004-12-06 | 2005-01-05 | Isis Innovation | Pyrrolidine compounds |
| US8143288B2 (en) | 2005-06-06 | 2012-03-27 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
| US7629340B2 (en) | 2005-12-12 | 2009-12-08 | Smithkline Beecham Corporation | N-(6-membered aromatic ring)-amido anti-viral compounds |
-
2006
- 2006-12-12 TW TW095146496A patent/TW200730476A/zh unknown
- 2006-12-12 BR BRPI0619730-2A patent/BRPI0619730A2/pt not_active IP Right Cessation
- 2006-12-12 CA CA002633569A patent/CA2633569A1/en not_active Abandoned
- 2006-12-12 WO PCT/US2006/047620 patent/WO2007070600A2/en not_active Ceased
- 2006-12-12 RU RU2008128453/04A patent/RU2008128453A/ru not_active Application Discontinuation
- 2006-12-12 EP EP06848636A patent/EP1971597A2/en not_active Withdrawn
- 2006-12-12 AU AU2006326443A patent/AU2006326443A1/en not_active Abandoned
- 2006-12-12 US US11/609,858 patent/US7595398B2/en not_active Expired - Fee Related
- 2006-12-12 KR KR1020087016882A patent/KR20080080170A/ko not_active Withdrawn
- 2006-12-12 JP JP2008545783A patent/JP2009519346A/ja active Pending
- 2006-12-12 CN CNA2006800466274A patent/CN101331125A/zh active Pending
- 2006-12-12 ZA ZA200805227A patent/ZA200805227B/xx unknown
-
2008
- 2008-05-26 IL IL191699A patent/IL191699A0/en unknown
-
2009
- 2009-08-20 US US12/544,273 patent/US20100004441A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006326443A1 (en) | 2007-06-21 |
| CN101331125A (zh) | 2008-12-24 |
| RU2008128453A (ru) | 2010-01-20 |
| BRPI0619730A2 (pt) | 2011-10-11 |
| IL191699A0 (en) | 2009-02-11 |
| CA2633569A1 (en) | 2007-06-21 |
| US20100004441A1 (en) | 2010-01-07 |
| TW200730476A (en) | 2007-08-16 |
| US20070265265A1 (en) | 2007-11-15 |
| JP2009519346A (ja) | 2009-05-14 |
| US7595398B2 (en) | 2009-09-29 |
| EP1971597A2 (en) | 2008-09-24 |
| WO2007070600A2 (en) | 2007-06-21 |
| KR20080080170A (ko) | 2008-09-02 |
| WO2007070600A3 (en) | 2007-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200805227B (en) | N-(5-memebered heteroarmatic ring)-amido anti-viral compounds | |
| IL191698A0 (en) | N-(6-membered aromatic ring)-amido anti-viral compounds | |
| ATE499369T1 (de) | Heterozyklische verbindung | |
| ZA200709051B (en) | Heterocyclic compound | |
| PL1937650T3 (pl) | Związki heterocykliczne | |
| AP2007004171A0 (en) | Novel compounds | |
| EP1841424A4 (en) | SYNTHESIS OF ARYL PYRROLIDONES | |
| ZA201107667B (en) | Anti-viral compounds | |
| EP1868612A4 (en) | NOVEL CONNECTIONS | |
| EP1868611A4 (en) | NOVEL CONNECTIONS | |
| GB2427522B (en) | Compound Loudspeaker | |
| ZA200800142B (en) | Heterocyclic compound | |
| ZA200803017B (en) | Heterocyclic compounds | |
| GB0500140D0 (en) | Novel compounds | |
| EP1869026A4 (en) | NEW CONNECTIONS | |
| HK1122303A (en) | N-(5-membered heteroaromatic ring)-amido anti-viral compounds | |
| GB0525033D0 (en) | New Anti-viral Compounds | |
| GB0506894D0 (en) | New anti-viral compounds | |
| UA11501S (uk) | Перстень | |
| GB0500887D0 (en) | Novel compounds | |
| GB0501961D0 (en) | Novel compounds | |
| GB0501959D0 (en) | Novel compounds | |
| GB0501094D0 (en) | Novel compounds | |
| GB0500925D0 (en) | Novel compounds | |
| GB0500923D0 (en) | Novel compounds |